{"chebi_id":"63912","chebi_name":"19-hydroxyprostaglandin H2","chebi_synonyms":["(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3,7-dihydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acid","(5Z,13E,15S)-9\u03b1,11\u03b1-epidioxy-15,19-dihydroxyprosta-5,13-dienoic acid","(5Z,9\u03b1,11\u03b1,13E,15S)-9,11-epidioxy-15,19-dihydroxyprosta-5,13-dien-1-oic acid"],"diffprof_id_observed":["MTBLS2145_0002_00000029"],"diffprof_id_var_observed":[],"inchikey":"MTVPUJQVDLAVML-AHYYGCRPSA-N","inn_name":"","iupac_name":"(5<i>Z</i>)-7-{(1<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-6-[(1<i>E</i>,3<i>S</i>)-3,7-dihydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acid","num_study_observed":1,"reactome_ids":["R-HSA-1430728","R-HSA-211859","R-HSA-211897","R-HSA-211945","R-HSA-211979"],"reactome_names":["Metabolism","Biological oxidations","Cytochrome P450 - arranged by substrate type","Phase I - Functionalization of compounds","Eicosanoids"],"study_id_observed":["MTBLS2145"],"study_id_var_observed":[],"synonym_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b1-epidioxy-15,19-dihydroxyprosta-5,13-dienoic acid"}